Business Wire

1. Parse Biosciences Announces FFPE-Compatible Barcoding Technology For Whole Transcriptome Single Cell Analysis 11/18/2025

   Parse Biosciences, the leading provider of scalable and accessible single cell sequencing solutions, today announced a breakthrough technology that unlocks the full potential of formalin-fixed, paraffin-embedded (FFPE) samples.

2. Augurex Life Sciences Corp. Announces The Launch Of The 14-3-3eta Test For Rheumatoid Arthritis Diagnosis And Monitoring With Sonic Reference Laboratory 11/17/2025

   Augurex Life Sciences Corp., a leader in the development of autoimmune-based diagnostics, today announced the upcoming launch of the 14-3-3eta test, approved as JOINTstat in Canada and the UK, through Sonic Reference Laboratory, a division of Sonic Healthcare USA.

3. OCEAN Dx Rapid Diagnostic Test For Sepsis Matched Gold Standard During A Clinical Evaluation Study 11/17/2025

   OCEAN Dx, a pioneer in rapid diagnostic solutions, announced the successful completion of a clinical evaluation study for its innovative rapid diagnostic test for sepsis.

4. Thermo Fisher Scientific Receives 510(k) Clearance In The United States For EXENT System^* To Aid In The Diagnosis Of Multiple Myeloma 11/12/2025

   Thermo Fisher Scientific Inc. the world leader in serving science, today announced 510(k) clearance of the EXENT Analyser and Immunoglobulin Isotypes (GAM) Assay^**, a first-of-its-kind automated platform for clinical laboratories.

5. Guardant Health Expands Tissue-Free Reveal Test To Include Late-Stage Therapy Response Monitoring 11/10/2025

   Guardant Health, Inc. a leading precision oncology company, today announced the expansion of its Guardant Reveal blood test to include late-stage therapy response monitoring for patients with solid tumors.

6. Exact Sciences Announces Breakthrough Results From Landmark Study Demonstrating Superior Early Detection Of Liver Cancer With Blood-Based Surveillance Test 11/7/2025

   Exact Sciences Corp a leading provider of cancer screening and diagnostic tests, today announced pivotal clinical validation results from the ALTUS study (NCT: 05064553).

7. Illumina And Grail Veterans Launch Hepta With First Liquid Biopsy-Native AI That Detects Liver Disease With Tissue-Level Biological Insights 11/5/2025

   Hepta, a biotechnology company using transformer-based AI to read the cell-free DNA (cfDNA) epigenome and detect organ-specific signals of chronic disease, today emerged from stealth with $6.7M in seed funding led by Felicis Ventures and Illumina Ventures, with participation from SeaX Ventures, Alumni Ventures, and AME Cloud Ventures.

8. QIAGEN To Acquire Parse Biosciences, Expanding Its Sample Technologies Portfolio Into Highly Scalable Single-Cell Solutions 11/4/2025

   QIAGEN today announced it has entered into a definitive agreement to fully acquire Parse Biosciences, a leading provider of scalable, instrument-free solutions for single-cell research.

9. Countable Labs Announces Additional Modules For Countable PCR Expanding Its Utility For Translational Research, Cell And Gene Therapy Manufacturing, And Diagnostic Development 11/4/2025

   Countable Labs, the developer of Countable PCR, the leading PCR innovation transforming how science measures biology, announced the launch of the RNA Module for Countable PCR.

10. SimplyTest Partners With Evexia Diagnostics To Expand Access To PERIO And 4-Point Cortisol Tests For Functional And Integrative Health Practitioners 11/4/2025

    SimplyTest is proud to announce a new partnership with Evexia Diagnostics, a premier provider of diagnostic laboratory services for functional and integrative medicine.